AbbVie’s psoriasis drug Skyrizi approved in JapanAbbVie’s hotly anticipated psoriasis drug Skyrizi (risankizumab) has been approved in Japan, the first country to okay this Share XAbbVie’s psoriasis drug Skyrizi approved in Japanhttps://pharmaphorum.com/news/abbvies-psoriasis-drug-skyrizi-approved-in-japan/
Genentech buys NASH biotech JecureRoche’s Genentech unit has bought California biotech Jecure Therapeutics, which is researching drugs that could be used in Share XGenentech buys NASH biotech Jecurehttps://pharmaphorum.com/news/genentech-buys-nash-biotech-jecure/
NHS saving £300m with Humira biosimilar dealThe NHS is to save £300 million after striking deals with several manufacturers of low cost biosimilars of Share XNHS saving £300m with Humira biosimilar dealhttps://pharmaphorum.com/news/nhs-saving-300m-with-humira-biosimilar-deal/
Samsung Bioepis’ Humira biosimilar launches in EUSamsung Bioepis has become the latest biosimilars company to confirm it has launched a cheaper near-copy of AbbVie’s Share XSamsung Bioepis’ Humira biosimilar launches in EUhttps://pharmaphorum.com/news/samsung-bioepis-humira-biosimilar-launches-in-eu/
Billions up for grabs as EU patent on AbbVie’s Humira expiresThe patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a Share XBillions up for grabs as EU patent on AbbVie’s Humira expireshttps://pharmaphorum.com/news/billions-up-for-grabs-as-eu-patent-abbvies-humira-expires/
Sandoz free to launch Humira biosimilar following AbbVie dealNovartis’ generics and biosimilars arm, Sandoz, has confirmed it is to launch its biosimilar of AbbVie’s Humira (adalimumab) Share XSandoz free to launch Humira biosimilar following AbbVie dealhttps://pharmaphorum.com/news/sandoz-free-to-launch-humira-biosimilar-following-abbvie-deal/
New data sets up potential new gastro use for J&J’s StelaraJanssen’s Stelara has shown positive results in an ulcerative colitis (UC) trial, setting up a potential new indication Share XNew data sets up potential new gastro use for J&J’s Stelarahttps://pharmaphorum.com/news/new-data-sets-up-potential-new-gastro-use-for-jjs-stelara/
Merck & Co signs biosimilars deal for US veteransMerck & Co has signed a deal with the US Department of Veterans Affairs (VA) for its inflammatory Share XMerck & Co signs biosimilars deal for US veteranshttps://pharmaphorum.com/news/merck-co-signs-biosimilars-deal-for-us-veterans/
Humira developer Winter among Nobel chemistry prize winnersA scientist who pioneered the technology used to discover the biggest selling drug in the world, AbbVie’s Humira, Share XHumira developer Winter among Nobel chemistry prize winnershttps://pharmaphorum.com/news/humira-developer-winter-among-nobel-chemistry-prize-winners/
